Skip to content

Clinical trials

Recruiting Carcinoma, Non-Small-Cell Lung trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Recruiting Country / region: China Clear all

456 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20161
20174
20183
20195
20208
202121
202241
202344
2024101
2025138
202688

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting456

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University17
Hunan Province Tumor Hospital16
AstraZeneca13
Fudan University12
Tianjin Medical University Cancer Institute and Hospital12
Shanghai Chest Hospital11
Shanghai Pulmonary Hospital, Shanghai, China10
Cancer Institute and Hospital, Chinese Academy of Medical Sciences9
Sichuan Baili Pharmaceutical Co., Ltd.9
Bristol-Myers Squibb7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung456
Lung Neoplasms63
Colorectal Neoplasms21
Breast Neoplasms17
Melanoma15
Carcinoma, Hepatocellular14
Small Cell Lung Carcinoma14
Neoplasm Metastasis13
Neoplasms13
Endometrial Neoplasms11

Trials

Showing 1 to 25 of 456. Each trial links to its page on Pharma Observatory.

356 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.